Key result
Riboflavin supplementation at or daily did not change albumin-adjusted serum free thiols compared to placebo in healthy individuals.
Why the study?
Riboflavin may alleviate oxidative stress by increasing extracellular antioxidant capacity, but its potential to improve systemic redox status in healthy volunteers was unknown.
Does riboflavin supplementation improve systemic redox status in healthy volunteers?
RCT (n=99)
Double-blind
Randomized
Does riboflavin supplementation improve systemic redox status in healthy volunteers?
Riboflavin supplementation does not significantly alter systemic redox status, as measured by serum free thiols, in healthy individuals.
Answers are grounded in this paper and cite their sources.
Riboflavin supplementation does not alter free thiol levels in healthy volunteers; challenges presumed antioxidant benefit and leaves effects in disease states open.
BACKGROUND: Riboflavin is a redox-active vitamin that plays a pivotal role in human energy metabolism. Riboflavin may have beneficial health effects by increasing extracellular antioxidant capacity, thereby alleviating oxidative stress. Reduced levels of free thiols in blood reflect systemic oxidative stress, since they are readily oxidized by reactive species. In this study, we aimed to study the potential of riboflavin supplementation to improve the systemic redox status in healthy volunteers. METHODS: This study was a post-hoc analysis of the RIBOGUT study, a randomized, double-blind, placebo-controlled human intervention trial that investigated the effect of riboflavin supplements on the gut microbiota composition of healthy individuals. Serum free thiols were quantified before and after intervention and adjusted to serum albumin levels. Changes in albumin-adjusted free thiols were analyzed, as well as potential associations with routine laboratory parameters and faecal bacterial quantification by fluorescence in-situ hybridization (FISH). RESULTS: Participants were randomized to either placebo (n = 34), riboflavin 50 mg daily (n = 32), or riboflavin 100 mg daily (n = 33). At baseline, no significant differences in albumin-adjusted serum free thiols were observed. After intervention with either placebo or riboflavin, albumin-adjusted serum free thiols did not significantly change (P > 0.05), however, observed changes were inversely associated with changes in C-reactive protein (CRP) levels (r = -0.22, P < 0.05). At baseline, albumin-adjusted serum free thiols were positively associated with faecal relative abundances of Faecalibacterium prausnitzii (P < 0.01). CONCLUSION: Riboflavin did not change the systemic redox status in healthy individuals as reflected by serum free thiols, but observed changes in albumin-adjusted free thiol levels were negatively associated with changes in CRP levels. Strikingly, albumin-adjusted free thiols were independently associated with relative abundances of faecal F. prausnitzii, which may suggest a potential host redox-microbiota interaction.
No takes yet. Share an insight, caveat, or question.
Bourgonje et al. (2022) conducted an RCT in Healthy volunteers (n=99). Riboflavin vs. Placebo was evaluated on Changes in albumin-adjusted serum free thiols (p=> 0.05). Riboflavin supplementation at or daily did not change albumin-adjusted serum free thiols compared to placebo in healthy individuals.
Synapse has enriched 10 related papers. Consider them for comparative context: